Glyphic Biotechnologies, Inc.
Funding rounds
1 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Feb 2024 | $33 M | No. 1 | $10 to $50 million | equity | SEC |
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Glyphic Biotechnologies, Inc. chose not to state its revenue in its newest notice of a funding round (Feb 2024).
SEC Form D · Feb 2024
The industry group it chose in its notices: Biotechnology.
SEC Form D · Feb 2024
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Glyphic Biotechnologies, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Daniel Estandian | Executive officer | Feb 2024 |
| Joshua Yang | Executive officer | Feb 2024 |
| Craig Asher | Director | Feb 2024 |
| Daniel Estandian | Director | Feb 2024 |
| Jimmy Yun | Director | Feb 2024 |
| Joshua Yang | Director | Feb 2024 |